Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study assessed time to recurrence of infection with Pseudomonas aeruginosa following
treatment of the initial infection with tobramycin nebuliser solution. The safety profile of
the initial tobramycin treatment was assessed during the first 3 months of the study and
patients were followed until the end of the study, month 27.